Drug Approval | August 06, 2021
India’s gets its first bio-bank for heart failure research
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
He will be stationed at the company HQ in Bengaluru, India
CDSCO to fast-track trials and approval for COVID19 vaccine
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Deal for 100 million doses with additional 100 million through 2023
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
The company has been consistently reducing debt
Subscribe To Our Newsletter & Stay Updated
